Literature DB >> 31384007

Rewiring regulatory T cells for tumour killing.

Tomasz Maj1, Weiping Zou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31384007      PMCID： PMC7268916          DOI： 10.1038/s41551-019-0443-y

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN： 2157-846X            Impact factor:   25.671


× No keyword cloud information.
  16 in total

1.  Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.

Authors:  Thomas Duhen; Rebekka Duhen; Antonio Lanzavecchia; Federica Sallusto; Daniel J Campbell
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

Review 2.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

Authors:  Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

Review 3.  Immunosuppressive networks in the tumour environment and their therapeutic relevance.

Authors:  Weiping Zou
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

4.  IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.

Authors:  Ilona Kryczek; Ke Wu; Ende Zhao; Shuang Wei; Linhua Vatan; Wojciech Szeliga; Emina Huang; Joel Greenson; Alfred Chang; Jacek Roliński; Piotr Radwan; Jingyuan Fang; Guobin Wang; Weiping Zou
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

5.  Posttranscriptional control of T cell effector function by aerobic glycolysis.

Authors:  Chih-Hao Chang; Jonathan D Curtis; Leonard B Maggi; Brandon Faubert; Alejandro V Villarino; David O'Sullivan; Stanley Ching-Cheng Huang; Gerritje J W van der Windt; Julianna Blagih; Jing Qiu; Jason D Weber; Edward J Pearce; Russell G Jones; Erika L Pearce
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

6.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

7.  Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

Authors:  Heng Lin; Shuang Wei; Elaine M Hurt; Michael D Green; Lili Zhao; Linda Vatan; Wojciech Szeliga; Ronald Herbst; Paul W Harms; Leslie A Fecher; Pankaj Vats; Arul M Chinnaiyan; Christopher D Lao; Theodore S Lawrence; Max Wicha; Junzo Hamanishi; Masaki Mandai; Ilona Kryczek; Weiping Zou
Journal:  J Clin Invest       Date:  2018-01-16       Impact factor: 14.808

8.  Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.

Authors:  Linhua Zou; Brian Barnett; Hana Safah; Vincent F Larussa; Melina Evdemon-Hogan; Peter Mottram; Shuang Wei; Odile David; Tyler J Curiel; Weiping Zou
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

9.  Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy.

Authors:  Mauro Di Pilato; Edward Y Kim; Bruno L Cadilha; Jasper N Prüßmann; Mazen N Nasrallah; Davide Seruggia; Shariq M Usmani; Sandra Misale; Valentina Zappulli; Esteban Carrizosa; Vinidhra Mani; Matteo Ligorio; Ross D Warner; Benjamin D Medoff; Francesco Marangoni; Alexandra-Chloe Villani; Thorsten R Mempel
Journal:  Nature       Date:  2019-05-15       Impact factor: 49.962

10.  mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.

Authors:  Hu Zeng; Kai Yang; Caryn Cloer; Geoffrey Neale; Peter Vogel; Hongbo Chi
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962
View more
  1 in total

1.  Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis.

Authors:  Ze-Bo Jiang; Ju-Min Huang; Ya-Jia Xie; Yi- Zhong Zhang; Chan Chang; Huan-Ling Lai; Wenjun Wang; Xiao-Jun Yao; Xing-Xing Fan; Qi-Biao Wu; Chun Xie; Mei-Fang Wang; Elaine Lai-Han Leung
Journal:  J Exp Clin Cancer Res       Date:  2020-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.